BioLineRx (BLRX) vs Chemomab Therapeutics (CMMB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BioLineRx (BLRX) has outperformed Chemomab Therapeutics (CMMB) over the past year, losing 50.3% versus a loss of 60.7%. Over five years, CMMB leads with a -96.2% price change compared with -98.2% for BLRX. BioLineRx is the larger company by market cap ($11.1 million vs $10.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLRX | CMMB |
|---|---|---|
| Share price | $2.22 | $1.38 |
| Market cap | $11.05M | $10.09M |
| 1-day change | +0.68% | +1.27% |
| YTD return | -20.40% | -16.97% |
| 1-year return | -50.34% | -60.69% |
| 5-year return | -98.20% | -96.23% |
| EPS (TTM) | $0.00 | $-1.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.50 | $3.55 |
| 52-week low | $2.15 | $1.05 |
| Distance from 52-week high | -50.67% | -61.20% |
| Average volume | 16.27K | 118.53K |
| Shares outstanding | 4.98M | 7.33M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BLRX has outperformed CMMB by 10.4 percentage points over the past year.
BLRX vs CMMB FAQ
Which is bigger, BioLineRx or Chemomab Therapeutics?
BioLineRx (BLRX) is larger, with a market capitalization of $11.05M compared with $10.09M for Chemomab Therapeutics (CMMB).
Which stock has performed better over the past year, BLRX or CMMB?
BLRX returned -50.34% over the past 12 months, compared with -60.69% for CMMB (price return, excluding dividends). Past performance does not predict future results.
Are BioLineRx and Chemomab Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.